Tickwind
HoyOportunidadesMercadosChat con IA
ES
Iniciar sesiónRegistrarse
Tickwind

Lee cada tick. Ve hacia dónde sopla el mercado.

  • XInglés
  • TelegramChino
  • BoletínInglés

Producto

  • Mercados
  • Zonas temáticas
  • Todas las acciones
  • Comparar
  • Acciones en tendencia
  • Oportunidades
  • Noticias
  • Discusión
  • Lista de seguimiento
  • Novedades

Cuenta

  • Ajustes
  • Boletín
  • Para prensa e investigación
  • Servidor MCP
  • Contacto
  • Iniciar sesión
  • Registrarse
MercadosZonas temáticasTodas las accionesCompararAcciones en tendenciaOportunidadesNoticiasDiscusiónLista de seguimientoNovedadesAjustesBoletínPara prensa e investigaciónServidor MCPContactoIniciar sesiónRegistrarse

© 2026 Tickwind. No es asesoría de inversión.

Hecho para el inversor curioso.

Home/CVSI/Filing changes

CVSI — what changed in the latest 10-Q

A section-by-section comparison of CVSI's newest periodic SEC filing (10-K/10-Q) against the prior same-form filing: paragraphs added and removed per section, with verbatim excerpts. Purely a deterministic text diff — no similarity scores, no directional read, not investment advice.

Comparing 10-Q · 2026-08-13 vs the prior 10-Q · 2026-05-15

SectionOutcomeAddedRemovedMinorUnchanged
MD&AText added/removed+32−20~1928
Market risk (Item 3)No paragraph-level changes0001
Controls & proceduresText added/removed00~20
Legal proceedingsText added/removed00~10
Other informationText added/removed00~10

Counts are paragraphs; added/removed means text added or removed vs the prior filing — no direction or judgement implied.

Not shown (absent or not faithfully extractable): Risk factors

Representative excerpts

Up to 5 excerpts of about 300 characters per section, quoted verbatim from the two SEC filings.

MD&A

Text added vs the prior filing · source: 10-Q · 2026-08-13

  • We had net product sales of $3.0 million and gross profit of $1.5 million, representing a gross margin of 48.6%, in the second quarter of 2026, compared to net product sales of $3.6 million and gross profit of $1.8 million, representing a gross margin of 50.9%, in the second quarter of 2025. Net pro…
  • 44.3% of our net revenue for the second quarter 2026 was from new products launched since January 1, 2023. During this time, we launched 52 new products. The overall market continues to be fragmented and highly competitive, which we believe is largely due to the lack of a clear regulatory framework …
  • Cost of goods sold consists primarily of raw materials, packaging, manufacturing overhead (including payroll, employee benefits, stock-based compensation, facilities, depreciation, supplies and quality assurance costs), merchant card fees and shipping. We were able to reduce our cost of goods sold i…
  • We had net product sales of $6.2 million and gross profit of $3.0 million, representing a gross margin of 48.7%, in the six months ended June 30, 2026, compared to net product sales of $7.2 million and gross profit of $3.5 million, representing a gross margin of 48.5%, in the six months ended June 3…
  • 43.5% of our net revenue for the six month ended June 30, 2026 was from new products launched since January 1, 2023. During this time, we launched 52 new products. The overall market continues to be fragmented and highly competitive, which we believe is largely due to the lack of a clear regulatory …

Text removed vs the prior filing · source: 10-Q · 2026-05-15

  • We had net product sales of $3.2 million and gross profit of $1.6 million, representing a gross margin of 48.9%, in the first quarter of 2026, compared to net product sales of $3.6 million and gross profit of $1.7 million, representing a gross margin of 46.0%, in the first quarter of 2025. Our net p…
  • Cost of goods sold consists primarily of raw materials, packaging, manufacturing overhead (including payroll, employee benefits, stock-based compensation, facilities, depreciation, supplies and quality assurance costs), merchant card fees and shipping. We were able to reduce our cost of goods sold i…
  • Research and development (“R&D”) expense decreased from the first quarter of 2025 due to overall reduced R&D spend associated with new consumer products development expenses.
  • Selling, general and administrative (“SG&A”) expense decreased to $1.9 million in the first quarter of 2026 compared to $2.1 million in the first quarter of 2025, which was primarily a result of the following:
  • Sales expense decreased due to lower commission, payroll, travel and other sales related expense.

How to read Risk Factors (Item 1A) in a 10-Q

A 10-Q risk-factor section usually takes one of three forms; this page classifies it as one of:

  • Pointer — the filer states there have been no material changes and points back to the annual 10-K risk factors; there is no own risk text to compare this quarter.
  • Partial update — the filer carves out specific updated risks ("except as set forth below"); the excerpts show exactly what is new this quarter.
  • Restated in full — the quarter carries the complete risk-factor text. When the prior quarter was only a pointer there is no prior full text to diff against, so the page flags the section as restated instead.

This describes the filing structure only — it is never a judgement on whether risk went up or down.

Source: text-level diff of the two SEC EDGAR filings · deterministic (no AI-generated content) · for reference only · not investment advice

More on CVSI

CVSI overviewCVSI quant ratingCVSI fair value (DCF)CVSI vs peersCVSI revenue historyCVSI AI deep research